Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform.
Saved in:
| Title: | Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform. |
|---|---|
| Authors: | Darwanto, Agus1,2, Hein, Anne-Mette3, Strauss, Sascha4, Yi Kong5, Sheridan, Andrew1, Richards, Dan5, Lader, Eric6, Ngowe, Monika1,7, Pelletier, Timothy1, Adams, Danielle1,8, Ricker, Austin1, Patel, Nishit1, Kühne, Andreas4, Hughes, Simon9, Shiffman, Dan5, Zimmermann, Dirk4, Kai te Kaat4, Rothmann, Thomas4 Thomas.rothmann@qiagen.com, Kong, Yi10 (AUTHOR), Te Kaat, Kai11 (AUTHOR) |
| Source: | BMC Cancer. 5/22/2017, Vol. 17, p1-8. 8p. 2 Color Photographs, 4 Charts, 1 Graph. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
